Delivery Order SPE2DB22D2007-SPE2DB24FJ1AE
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $16,101.43 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide STELARA 90 MG/ML syringes. The contract has a ceiling value of $20,566.14 and a performance period through April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for $40,369.49. The contract is for the supply of STELARA 90 MG/ML syringes and has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order contract is part of a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Stelara 90 mg/ml syringes. The contract has a ceiling value of $17,026.75 and a period of performance through March 19, 2024. This delivery order is part of a larger single award Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract valued at $30,858.83 for the supply of STELARA 90 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGEML. The $31,425.34 contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to provide pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML SYRINGE. The award has a potential value of $8,081.84 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply STELARA 90 MG/ML syringes. The contract has a potential value of $100,647.90 and a period of performance through February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, which does not have a set-aside designation. The company also holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a $63,977.75 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of STELARA 90 MG/ML syringes. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables Amerisourcebergen to deliver a comprehensive range of...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of STELARA 90 MG/ML SYRINGE, with a potential value of $8,108.92 and a performance period through February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. The company also holds an...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ1AEDelivery Order
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed price delivery order contract to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation. The contract has a ceiling value of $9,847.60 and a period of performance through March 29, 2024. The contract is for the delivery of STELARA 90 MG/ML syringes, a specialty pharmaceutical product. No set-aside designation was used for this award. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. This IDC was awarded solely to AmerisourceBergen Drug Corp.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 3/28/24 |